Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice

Hepatology

Volumn 38, Issue 1, 2003, Pages 123-132

  Ip, Emilia ^a   Farrell, Geoffrey C ^a,c   Robertson, Graham ^a   Hall, Pauline ^b   Kirsch, Richard ^b   Leclercq, Isabelle ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; ACYL COENZYME A OXIDASE; ALANINE AMINOTRANSFERASE; CHOLINE; CYTOCHROME P450 2E1; CYTOCHROME P450 4A; FATTY ACID; FATTY ACID BINDING PROTEIN; KETOTHIOLASE; LIPID; LIPID PEROXIDE; MESSENGER RNA; METHIONINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ALKANE 1 MONOOXYGENASE; CELL RECEPTOR; CYP4A14 PROTEIN, MOUSE; CYTOCHROME P450; HYPOCHOLESTEROLEMIC AGENT; MIXED FUNCTION OXIDASE; PIRINIXIC ACID; PYRIMIDINE DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FATTY ACID OXIDATION; FATTY LIVER; INFLAMMATION; LIPID METABOLISM; LIPID PEROXIDATION; LIVER INJURY; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; UPREGULATION; ANIMAL; ANIMAL FOOD; BLOOD; C57BL MOUSE; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; LIVER; METABOLISM; MICROSOME; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAMIN DEFICIENCY;

ALKANE 1-MONOOXYGENASE; ANIMAL FEED; ANIMALS; ANTICHOLESTEREMIC AGENTS; CHOLINE DEFICIENCY; CYTOCHROME P-450 ENZYME SYSTEM; FATTY ACIDS; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPID PEROXIDATION; LIVER; MALE; METHIONINE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROSOMES; MIXED FUNCTION OXYGENASES; PYRIMIDINES; REACTIVE OXYGEN SPECIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 0038643427     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50307     Document Type: Article

References (50)

1. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594-598.
2. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. HEPATOLOGY 2002;35:373-379.
3. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. HEPATOLOGY 1990;11:74-80.
4. Hui JM, Farrell GC. Clear messages from sonographic shadows? Links between metabolic disorders and liver disease, and what to do about it. J Gastroenterol Hepatol 2003;18 (in press)
5. Day CP, James OFW. Steatohepatitis: a tale of two "hits." Gastroenterology 1998;114:842-845.
6. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:27-41.
7. Tsutsumi M, Takada A, Wang JS. Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 1994;107:1430-1435.
8. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. HEPATOLOGY 1998;27:128-133.
9. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat model of hepatic steatosis with inflammation. Gastroenterology 1996;111:1645-1653.
10. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000;105:1067-1075.
11. Fan C, Pan J, Chu R, Lee D, Kluckman KD, Usuda N, Singh I, et al. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J Biol Chem 1996;271:24698-24710.
12. Tugwood JD, Isseman I, Anderson RG, Bundell KR, McPheat WL, Green S. The mouse peroxisome proliferator activated receptor recognises a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 1992;11:433-439.
13. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. Altered constitutive expression of fatty acid-metabolising enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem 1998;273:5678-5684.
14. Kroetz DL, Yook P, Costet P, Bianchi P, Pineau T. Peroxisome proliferator-activated receptor α controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J Biol Chem 1998;273:31581-31589.
15. Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, Gonzalez FJ, et al. Peroxisomal and mitochondrial fatty acid β-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor α and peroxisomal fatty acyl-CoA oxidase. J Biol Chem 1999;274:19228-19236.
16. Robertson GR, Leclercq IA, Farrell GC. Nonalcoholic steatohepatitis II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 2001;281:G1135-G1139.
17. Lee S, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero M, et al. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotrophic effects of peroxisome proliferators. Mol Cell Biol 1995;15:3012-3022.
18. Murray M, Zaluzny L, Farrell GC. Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isoenzymes in the choline-deficient rat model. Biochem Pharmacol 1986;35:1817-1824.
19. Heng YM, Kuo CWS, Jones PS, Savory R, Schultz RM, Tomlinson SR, Gray TJB, et al. A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not CYP4F, genes in mouse and humans. Biochem J 1997;325:741-749.
20. Bell R, Plant NJ, Rider CG, Na L, Brown S, Ateitalla I, Acharya SK, et al. Species-specific induction of cytochrome P-450 RNAs: PCR cloning of partial guinea pig, human and mouse. Biochem J 1993;294:173-180.
21. Meijer J, Afzelius BA. Effects of clofibrate treatment and of starvation on peroxisomes, mitochondria, and lipid droplets in mouse hepatocytes: a morphometric study. J Ultrastruc Mol Struc Res 1989;102:87-94.
22. Wolfrum C, Buhlmann C, Rolf B, Börchers T, Spener F. Variation of liver-fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxsome proliferators and antisense RNA affects the rate of fatty acid uptake. Biochim Biophys Acta 1999;1437:194-201.
23. Henderson CJ, Bammler T, Wolf CR. Deduced amino acid sequence of a murine cytochrome P-450 Cyp4a protein: developmental and hormonal regulation in liver and kidney. Biochim Biophys Acta 1994;1200:182-190.
24. Mitchell SR, Sewer MB, Kardar SS, Morgan ET. Characterization of CYP4A induction in rat liver by inflammatory stimuli: dependence on sex, strain, and inflammation-evoked hypophagia. Drug Metab Disp 2001;29:17-22.
25. Nakajima T, Kamijo Y, Usuda N, Liang Y, Fukushima Y, Kametani K, Gonzalez FJ, et al. Sex-dependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator-activated receptor α (PPARα). Carcinogenesis 2000;21:677-682.
26. Kishimoto R, Ogishi Y, Ueda M, Matsusaki M, Amako K, Goda K, Park SS. Gender-related differences in mouse hepatic ethanol metabolism. J Nutr Sci Vitaminol 2002;48:216-24.
27. Roe AL, Howard G, Blouin R, Snawder JE. Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice. Int J Obes Relat Metab Disord 1999;23:48-53.
28. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 1999;103:1489-1498.
29. Mancini FP, Lanni A, Sabatino L, Moreno M, Giannino A, Contaldo F, Colantuoni V, et al. Fenofibrate prevents and reduced body weight gain and adiposity in diet-induced obese rats. FEBS Lett 2001;491:154-158.
30. Nagai Y, Nishio Y, Nakamura T, Maegawa H, Kikkawa R, Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPARα. Am J Physiol Endocrinol Metab 2002;282:E1180-E1190.
31. Rao MS, Papreddy K, Musunuri S, Okonkwo A. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats. In Vivo 2002;16:145-152.
32. Chou CJ, Haluzik M, Gregory C, Dietz KR, Vinson C, Gavrilova O, Reitman ML. WY14,643 a peroxisome proliferator-activated receptor α (PPARα) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J Biol Chem 2002;277 24484-24489.
33. Oliveira CP, da Costa Gayotto LC, Tatai C, Della Bina BI, Janiszewski M, Lima ES, Abdulla DS, et al. Oxidative stress in the pathogenesis or nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med 2002;6:399-406.
34. Leclercq IA, Farrell GC, Schreimer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 2002;37:206-213.
35. Kumagai T, Kawamoto Y, Nakamura Y, Hatayama I, Satoh K, Osawa T, Uchida K. 4-hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem Biophys Res Commun 2000;273:437-441.
36. Curzio M, Esterbauer H, Dianzani MU. Chemotactic activity of hydroxyalkenals on rat neutrophils. Int J Tissue React 1985;7:137-142.
37. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995;96:2461-2468.
38. Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx J. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J Biol Chem 1997;272:27307-27312.
39. Motojima K, Passily P, Peters JM, Gonzalez FJ, Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue- and inducer-specific manner. J Biol Chem 1998;273:16710-16714.
40. Leone TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 1999;96:7473-7478.
41. Wan YJY, Cai Y, Li J, Yuan QX, French B, Gonzalez FJ, French S. Regulation of peroxisome proliferator activated receptor α-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice. Hepatol Res 2001;19:117-130.
42. Delerive P, Bosschert Kd, Besnard S, Berghe WV, Peters JM, Gonzalez FJ, Fruchart JC, et al. Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem 1999;274:32048-32054.
43. Delerive P, Gervois P, Fruchart JC, Staels B. Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators. J Biol Chem 2000;275:36703-336707.
44. Guéraud F, Alary J, Costet P, Debrauwer L, Dolo L, Pineau T, Paris A. In vivo involvement of cytochrome P450 4A family in the oxidative metabolism of the lipid peroxidation product trans-4-hydroxy-2-nonenal, using PPARα-deficient mice. J Lipid Res 1999;40:152-159.
45. 4 pathway to inflammation control. Nature 1996;384:39-43.
46. Hertz R, Bar-Tana J. Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans. Toxicol Lett 1998;102103:85-90.
47. Palmer CNA, Hsu MH, Griffin KJ, Raucy JL, Johnson EF. Peroxisome proliferator activated receptor-α expression in human liver. Mol Pharmacol 1998;53:14-22.
48. Hsu M-H, Savas U, Griffin KJ, Johnson EF. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor α in HepG2 cells. J Biol Chem 2001;276:27950-27958.
49. Yu S, Cao WQ, Kashireddy P, Meyer K, Jia Y, Hughes DE, Tan Y, et al. Human peroxisome proliferator-activated receptor α (PPARα) supports the induction of peroxisome proliferation in PPARα-deficient mouse liver. J Biol Chem 2001;276:42485-42491.
50. Flavell DM, Torra IP, Jamshidi Y, Evans D, Diamond JR, Elkeles RS, Bujac SR, et al. Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia 2000;43:673-680.